Comment on "Survival After Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases"
- PMID: 32398488
- DOI: 10.1097/SLA.0000000000003960
Comment on "Survival After Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases"
Comment in
-
Response to the Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases".Ann Surg. 2021 Dec 1;274(6):e721-e722. doi: 10.1097/SLA.0000000000003953. Ann Surg. 2021. PMID: 32502081 No abstract available.
Comment on
-
Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.Ann Surg. 2020 Feb;271(2):212-218. doi: 10.1097/SLA.0000000000003404. Ann Surg. 2020. PMID: 31188200 Clinical Trial.
References
-
- Dueland S, Syversveen T, Solheim JM, et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann Surg 2020; 271:212–218.
-
- Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013; 14:1208–1215.
-
- Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nature Med 2015; 21:1350–1355.
-
- Pitroda SP, Khodarev NK, Huang L, et al. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun 2018; 9:1–8.
-
- Gagnière J, Aurélien D, Gholami S, et al. Is hepatectomy justified for BRAF mutant colorectal liver metastases. Ann Surg 2020; 271:147–154.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical